Moreover, IL-10 treatment inhibited these alterations in the pancreas in both SPX wild-type and IL-10KO mice, thus supporting the hypothesis that obesity-induced reductions in IL-10 derived from the spleen may result in pancreatic damage. This evidence concerns the gene IL10 and obesity disorder.